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Anti-­‐Hu  antibodies  activate  enteric  
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enteric  neurons  and  cause  an  immediate  spike  discharge  in  enteric  and  visceral  sensory  neurons.  Both  
labelling  and  activation  of  enteric  neurons  was  prevented  by  preincubation  with  the  HuD  antigen.  
Activation  of  enteric  neurons  was  inhibited  by  the  nicotinic  receptor  antagonists  hexamethonium  and  
dihydro-­‐β?????????????????????????? ?????? ?????????????????????????????????????????????????????
???????????????????????? ??????? ??????????????????????????????????? ?????? ?????? ?????????? ???????
ω-­‐Conotoxin  GVIA.  Ca++?? ???????????? ???????????????????????????????????? ??????? ???????????????
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evidence  for  a  novel  link  between  nerve  activation  and  symptom  generation  in  patients  with  antibody-­‐
mediated  gut  dysfunction.
Neuro-immune interactions are thought to play a pathogenic role in patients with a variety of gastrointesti-
nal neuromuscular or neuroepithelial disease1. In a subset of these patients, the in!ammatory/immune insult 
is such as to de"ne an enteric neuropathy, a term used to indicate the predominant involvement of the intrinsic 
innervation supplying the gut, i.e. the enteric nervous system (ENS)2. #e classic histopathological correlate of 
in!ammatory neuropathies is a dense in"ltrate of CD3+ T lymphocytes (and, to a lower extent, plasma cells) 
localized within the two ganglionated plexuses of the ENS (hence the term ‘enteric ganglionitis’). For reasons 
that are still unclear, the in!ammatory in"ltrate more commonly a$ects myenteric (i.e. ‘myenteric ganglionitis’) 
rather than submucosal ganglia, although immune cell density is higher in the submucous and epithelial layers. 
Also, myenteric ganglionitis is usually accompanied by an in!ammatory axonopathy, i.e. axons from myenteric 
neurons exhibit a lympho-plasmacellular in"ltrate3. #e in!ammatory/immune-mediated changes within enteric 
ganglia and nerves can occur at any level of the gastrointestinal tract leading to severe gut dysmotility and delayed 
transit, detectable in conditions such as achalasia, gastroparesis, intestinal pseudo-obstruction and colonic iner-
tia/megacolon. If unopposed by any pharmacological treatment (i.e., immunosuppressants), the in!ammatory/
autoimmune injury of the ENS can progress towards neuronal damage and loss with further deterioration of gut 
function.
In addition to the activation of immunocytes, patients with in!ammatory neuropathies may develop a strong 
humoral response with a wide array of circulating anti-neuronal antibodies targeting molecules expressed by neu-
rons, including the RNA binding protein Hu (anti-Hu also referred to as type-1 anti-neuronal nuclear antibodies 
or ANNA-1)4,5. Whereas HuA (HuR) is ubiquitously present, HuB, HuC and HuD are speci"cally expressed in 
neurons and located in the nucleus or cytoplasm. However, it is the HuD antigen that is most frequently produced 
by small cell lung cancer cells. In most cases anti-HuD antibody associated syndromes occur with lung cancer, 
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in particular small cell lung cancer. Although anti-neuronal antibodies can be sometimes found in the sera of 
patients with idiopathic ganglionitis, they are usually detected in cases of gut motor disorders associated with 
paraneoplastic syndromes6,7. #e detection of anti-neuronal antibodies can be useful to guide an appropriate 
diagnostic approach, but their pathogenic role in ENS damage is still unsettled. It can be tentatively speculated 
that the activation of the immune system facilitates the access of immunocytes to the ENS microenvironment, 
as re!ected by the histopathological changes found in enteric ganglionitis3. #is would allow direct exposure 
of enteric neurons to IgGs. Incubation of cultured myenteric neurons with Hu-positive sera from patients with 
paraneoplastic gut dysmotility as been shown to cause apoptosis8. Similar damage to enteric neurons may occur 
in patients with irritable bowel syndrome (IBS), a condition characterized by a cluster of symptoms such as 
abdominal pain and bowel habit changes, who have circulating antibodies against enteric neurons9. #e patho-
logical e$ects of autoantibodies vary according to the target antigen, but neuronal dysfunction may be reversed 
with antibody-depleting therapies10. Although there is consensus about the neuronal damage or loss of function 
evoked by chronic exposure to some circulating antibodies, the acute e$ects of autoantibodies on neuronal func-
tion is unknown.
#us the aim of the present study was to determine the e$ect of sera from paraneoplastic syndrome patients 
with elevated ANNA-1 level on action potential discharge of human and guinea-pig enteric neurons as well as on 
mice visceral a$erent nerves. We also tested if the puri"ed IgG fractions or the puri"ed HuD-antibody were able 
to mimic the e$ect of the sera.
Materials  and  Methods
For the study we used human serum samples and human and guinea pig tissue samples. #e experimental pro-
tocols were approved by the #e Mayo Clinic institutional review board (IRB # 08-005481 for sampling of sera) 
and the Ethic Committee of the Technical University of Munich (Project approval 1746/07 and 1512/06 for 
tissue sampling). Patients gave written informed consent. All studies were conducted in accordance with the 
Declaration of Helsinki (Prot.n. 906/2006 and Prot.n 1925/2004) and methods were carried out in accordance 
with approved guidelines.
All animal studies were carried out in accordance with the German guidelines for animal protection and 
animal welfare and with approval of the local animal ethical committee at district veterinary o%ce of Munich.
???????????????????????? ????????????? ??????????????????? IgGs were puri"ed from sera of seven 
patients with paraneoplastic syndrome evoking gut dysfunction (i.e., a severe panenteric motility disorder such as 
chronic intestinal pseudo-obstruction) and high ANNA-1 titers (Table 1) and a group of 8 age- and sex-matched 
healthy controls. #e ANNA-1 containing patient sera tested negative for antibodies against voltage-gated potas-
sium channels, N-type calcium channels, P/Q-type calcium channels, muscle nicotinic acetylcholine receptors 
(α 1 subunit), neuronal nicotinic acetycholine receptors (α 3 subunit), collapsin response-mediator protein 5, 
glutamic acid decarboxylase, Purkinje cell cytoplasmic autoantibody type 1 and striational antibodies11.
????????????????????????????????????????????????? Preparation of recombinant HuD. Human HuD 
(Acc. NM_021952) was expressed in E. coli BL21 as previously described12. Full length cDNA coding for HuD 
was ligated into pET24d (Novagen) in frame with the coding sequence for a C-terminal histidyl octamer to allow 
metal chelate chromatography puri"cation. Expression was obtained using the pET system standard conditions. 
Recombinant HuD-His was puri"ed from inclusion bodies by di$erential centrifugation, extraction in 5 mM 
tris-HCl pH 8, 300 mM NaCl, 8 M urea, and subsequently metal chelate chromatography on NiNTA sepharose 
(Qiagen). #e protein was eluted in 50 mM sodium acetate pH 4.5, 8 M urea.
Coupling of recombinant HuD to NHS activated sepharose. Puri"ed, denatured HuD-His was mixed with four 
volumes of refolding bu$er (200 mM ethanolamine pH 10, 500 mM NaCl with 50% (w/v) glycerol) and dialyzed 
Patient Sex Age ANNA-1 titer Total IgG [mg/ml] Clinical information
#2 M 72 15,360 2.12 Chronic intestinal pseudoobstruction
#3 M 61 61,440 6.27 Smoker, chronic intestinal pseudoobstruction, Small cell lung cancer
#9 F 76 15,360 1.28 Graves disease, chronic intestinal pseudoobstruction
#10 F 67 61,440 1.97 Chronic intestinal pseudoobstruction, small cell lung cancer
#14 M 76 1,22,880 1.8 Chronic intestinal pseudoobstruction, small cell lung cancer
#17 M 76 7,680 5.14
Smoker, chronic obstructive pulmonary 
disease, Autoimmune gastrointestinal 
dysmotility, chronic intestinal 
pseudoobstruction, fatigue syndrome, anorexia
#20 F 44 30,720 11.24 Ex-smoker, subacute sensory neuronopathy. Chronic intestinal pseudoobstruction
#27 F 36 50,000 Not determined Chronic intestinal pseudoobstruction
Table 1.  Characteristics of patients (ANNA1 samples) and controls.
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against coupling bu$er (200 mM NaHCO3, pH 8.3, 500 mM NaCl). Insoluble material was removed by "ltration 
with a 0.2 µ m "lter. A 1 ml HiTrap NHS column (GE Healthcare, Freiburg, Germany) was washed with ice-cold 
HCl (1 mM) and coupling bu$er and then loaded with 1.5 mg soluble HuD-His in 1 ml coupling bu$er for 30 min 
at room temperature. A'er 3 washes with high pH bu$er (500 mM ethanolamine pH 8.3, 500 mM NaCl) and low 
pH bu$er (500 mM sodium acetate pH 4, 500 mM NaCl), respectively, the column was "nally washed with PBS.
#e HuD-column was used to purify anti-HuD autoantibodies from the serum of a patient with chronic 
intestinal pseudo-obstruction of non-paraneoplastic origin (Table 1, #27)8. #is serum was used to obtain puri-
"ed human anti-HuD. #e serum (anti-Hu 1:1000) was 1:4 diluted with PBS, sterile "ltered and passed onto the 
HuD-column. A'er washing the column with PBS (10 ml) anti-HuD was eluted with 200 mM glycine at pH 2.5. 
Eluate fraction was neutralized with one volume of 7.5% (w/v) Na2CO3) and then dialyzed "ve times against 10 
volumes PBS. #e titer of the puri"ed anti-HuD was 1:320.
Immunohistochemistry.   Tissue specimens of adult male guinea pigs (weight 250 g–550 g) ileal longitu-
dinal muscle myenteric plexus preparations were "xed overnight at room temperature in a solution containing 
4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate bu$er and then washed (3 × 10 min) in phos-
phate bu$er. A'er 1 hr incubation in PBS plus Triton-X-100 (TX100; 0.5%) and horse serum (4%), the patient 
#27 serum, puri"ed IgG control and patient samples (1:500 each), puri"ed human anti-HuD (from patient #27, 
1:5,000–1:20,000), mouse anti-HuC/D (1:50, #ermo Fisher Scienti"c, Waltham, MA, USA), goat anti-CD64 
(label for Fcγ receptor, 1:200, Santa Cruz Biotechnology, Heidelberg, Germany), or rabbit anti-neuron-speci"c 
enolase (NSE, 1:3000, Polysciences, Eppelheim, Germany) were added for 12–16 hrs. A'er washing (3 × 10 min 
in PBS) the preparations were incubated for 6 hours with species speci"c secondary antibodies coupled to !uoro-
phores (all from Dianova, Hamburg, Germany); Cy3-conjugated anti human or anti goat IgG (1:500, Dianova, 
Hamburg, Germany), Dylight 488 conjugated anti-rabbit or anti-human IgG (1:200), or streptavidin-Cy3 conju-
gated anti-mouse IgG (1:200). A'er the "nal washing, the tissues were mounted on poly-l-lysine coated coverslips 
and evaluated with an Olympus Microscope BX61 WI (Olympus, Hamburg, Germany) with appropriate "lter 
blocks. #e microscope was equipped with a SIS Fview II CCD-camera and the analySIS 3.1 so'ware (Olympus 
So' Imaging Solutions GmbH, Münster, Germany) for image acquisition and analysis. #e speci"city of the puri-
"ed anti-HuD was tested by preincubation of the antibody with the HuD antigen13 or a fragment of the antigen 
containing the amino acids (aa) 90–101 (gfvnyidpkdae) (Department of Molecular Biology and Biotechnology, 
University of She%eld, UK). #is fragment represents the epitope recognized by all anti-HuD containing patient 
sera14. For these experiments the antibody was used at a dilution of 1:20,000 which corresponded to ~26 pmol/l 
anti-HuD IgG. #e HuD antigen was added at concentrations between 2.4 and 480 nmol/l and the 90–101aa HuD 
fragment between 0.44 and 440 µ mol/l. A'er overnight incubation of antibody and antigens, the mixture was 
used for staining as described above.
?????????????????????????????????? ?++  sensitive  dye  imaging.   #e imaging techniques to record 
neural activity in the ENS were previously described15–17. Human tissue was obtained from patients undergo-
ing abdominal surgery in the Departments of Surgery at Clinic Freising and Clinic Rechts der Isar. Samples 
were taken from macroscopically normal, una$ected areas as determined by visual inspection of the pathologist. 
Tissues were placed in cold oxygenated sterile Krebs solution containing (in mM): 117 NaCl, 4.7 KCl, 1.2 MgCl2 
6H2O, 1.2 NaH2PO4, 25 NaHCO3, 2.5 CaCl2 2H2O and 11 glucose (all chemicals from Sigma-Aldrich). A'er 
arriving in the laboratory intestinal tissues were further dissected in ice-cold sterile oxygenated Krebs solution 
to obtain a preparation of the intact inner submucous plexus. Ileum preparations from adult male guinea pigs 
(weight 250–550 g) were obtained a'er killing the animals by cervical dislocation. #e tissues were further dis-
sected to obtain longitudinal muscle/myenteric plexus or lamina propria/submucous plexus preparations.
#e "nal preparations were placed in the recording chamber and continuously perfused with 37 °C Krebs 
solution. #e tissue chamber with the guinea pig or human preparation was mounted onto an epi!uorescence 
Olympus IX 50 microscope (Olympus, Hamburg, Germany) equipped with a 150 W xenon arc lamp (Osram, 
Munich, Germany). In the majority of experiments illumination periods of 1.3–5 sec (potentiometric dye) or 
up to 30 sec (Ca++ sensitive dye) were used, which were su%cient to record representative responses. Enteric 
neurons were stained with the fluorescent voltage sensitive dye Di-8-ANEPPS (1-(3-sulfonatopropyl)-4-[β 
[2-(di-n-octylamino)-6-naphthyl]vinyl]pyridinium betaine, life technologies, Darmstadt, Germany) or 
Fluo4-AM. Di-8-ANEPPS or Fluo4-AM stained preparations were visualized with oil immersion objectives 
(UAPO/340 Olympus, Hamburg, Germany) and neural activity was recorded at a single cell level with a pho-
todiode or CCD based system, respectively (NeuroPDA or NeuroCCD system, RedShirt Imaging, Decatur, GA, 
USA). We tested responsiveness of neurons by evoking fast excitatory postsynaptic potentials (fast EPSPs) a'er 
electrical stimulation of interganglionic "ber tracts with a monopolar platinum electrode or by pressure ejection 
of nicotine. Raw signals were converted to relative changes in !uorescence (∆ F/F) and analyzed with Neuroplex 
(RedShirt Imaging) or Fiji18.
Sera or puri"ed IgGs were applied to single ganglia by pressure ejection from micropipettes (20 psi, 400 ms 
duration, 200 µ m distance to the ganglion). Any substance in the microejection pipette was diluted by a factor of 
approximately 10 before reaching the ganglion19. Antagonists were added directly to the superfusing Krebs solu-
tion. We used the non-selective nicotinic receptor antagonist hexamethonium (100–200 µ M, Sigma-Aldrich), the 
β 2 subunit preferring nicotinic receptor antagonist dihydro-β -erythroidine (10 µ M, Sigma-Aldrich), the 5-HT3 
receptor antagonist tropisetron (0.1 µ M, gi' from Sandoz), the P2X receptor antagonist pyridoxal phosphate-
6-azo (benzene-2,4-disulfonic acid) tetrasodium salt hydrate (PPADS, 10 µ M, Sigma-Aldrich) and the N-type 
Ca++ channel blocker ω -Conotoxin GVIA (60 nM, Alomone labs, Israel).
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???????????????????? #ese experiments were performed at the University of She%eld under licence from 
the UK Animals Scienti"c Procedures Act (1986). Experiments were performed in tissues from 14 C57Bl6 mice of 
either sex (8–12 weeks old, 20–30 g). Mice were killed by cervical dislocation and the stomach and distal esopha-
gus were removed into oxygenated (95% O2 and 5% CO2; pH = 7.40) Krebs solution. #e gastric fundus together 
with the distal esophagus were isolated, thoroughly cleaned with Krebs solution and opened along the lesser 
curvature to obtain a !at sheet preparation. #e mucosa was removed and "ne branches of the vagus nerve inner-
vating the fundus were preserved. Vagal multi"bre a$erent discharge was recorded with extracellular suction elec-
trode (tip diameter 50–100 µ m) as previously described in detail20,21. #e electrode was connected to a Neurolog 
headstage (NL100, Digitimer, Welwyn Garden City, UK) and the signal was ampli"ed (NL104, Digitimer) and 
"ltered with a band pass 200–3000 Hz (NL 125, Digitimer). #e nerve signal was acquired (20 kHz sampling 
rate) through a Micro 1401 interface (CED, Cambridge Electronic Design, Cambridge, UK) and analyzed using 
Spike2 so'ware (version 5.03, CED). In addition to the raw nerve signals, a$erent "bers activity was recorded 
as a rate histogram with spike discriminating so'ware to identify single units. Mechanosensitive receptive "elds 
were located by probing the serosal surface with von Frey "laments (tip diameters < 50 µ m), exerted a force of 
1–2 mN. In some preparations the bu$er was switched to a calcium-free Krebs with MgCl2 at a concentration of 
3.6 mmol/L. Chemical stimulation was achieved via a silicone ring (approximately 100 µ l volume) placed over the 
receptive ‘hot spot’. A$erent units "rst were initially tested for their sensitivity to the nicotinic receptor agonist 
1, 1-dimethyl-4-phenylpiperazinium iodide (DMPP, 100 µ mol/l, Sigma) and/or adenosine 5′ -triphosphate (ATP, 
100 µ mol/l, Sigma). #en anti-HuD sample (patient #27) was applied. #e anti-HuD sample was stored at 4 °C in 
aliquots and diluted 1:10 with Krebs solution just before the experiments.
Data  analysis  and  Statistics.   Individual enteric neurons can be visualized in the neuroimaging experi-
ments because the voltage sensitive dye incorporates into the outer neuronal membrane, thereby revealing the 
outline of individual cell bodies. #is allowed us to determine the total number of neurons in each ganglion. 
For analysis, the optical signals were superimposed onto the image of the ganglion. For each ganglion, the total 
number of neurons and the number of neurons showing a response to the application of the compounds were 
calculated. Data were expressed as number of responding neurons vs. number of all neurons and mean fre-
quency ± standard error or median frequency [Q0.25/Q0.75] over all responding neurons. #e neuroindex was 
calculated by multiplying the percentage of responding neurons with the mean or median response frequency. 
Di$erences between these data were tested with t-tests/rank sum tests or one way ANOVA/repeated measures 
ANOVA on rank. Di$erences in the number of responding neurons were tested with χ 2-test/Fisher exact test or 
McNemar test (for repeated measures). Correlations were tested with the Pearson Product Moment correlation 
test. A P value < 0.05 was considered statistically signi"cant. For multiple comparisons we applied a Bonferroni 
correction. #e so'ware for statistical calculations was SigmaPlot 12.5 (Systat So'ware Inc., Erkrath, Germany) 
or Igor Pro 6.3 (Wavemetrics, Lake Oswego, OR, USA). A$erent neurograms were analyzed using Spike2 so'ware 
to calculate the "ring rate of spikes crossing a preset threshold in sequential time bins. #e gastric vagal a$erent 
activity was expressed as mean spikes frequency over the period of the response. Peak discharge rate was deter-
mined over a 3 s period around the maximal response. #e latency was measured from sample application to a 
20% increase in "ring rate above baseline activity or when a peak was reached. Statistical analysis of neurogram 
data was performed using GraphPad Prism version 4.01 (GraphPad So'ware, San Diego, CA, USA). Data are 
expressed as medians and compared using Wilcoxon Signed Rank Test.
Results
??????????????????????????????????????????????????????????????????????????????????? We 
assessed the ability of patient #27 serum, puri"ed IgGs from patient or control sera and puri"ed anti-HuD to 
bind to targets in the myenteric plexus of the guinea-pig ileum. All samples, except those from healthy controls, 
revealed strong staining of enteric cell bodies but no staining of neuronal processes (Fig. 1). While 6 samples 
stained nuclei and somata, one sample (#2) showed labeling of neuronal nuclei only. #e eight puri"ed IgG sam-
ples from healthy controls showed no staining of enteric neurons or any other structure in the preparations. 
Importantly, staining with the puri"ed anti-HuD was identical to the staining pattern observed with the whole 
serum or the puri"ed patient IgG samples. Preincubation with the HuD antigen in excess of 1,800 or 18,000 
reduced or blocked the staining by the puri"ed anti-HuD. However, staining by anti-HuD was not a$ected by pre-
incubation with the aa90–101 HuD fragment even at concentrations that correspond to a 17 million fold excess 
of the fragment over the antibody.
???????? ???????????????????????????????????????????? ???????? We "rst studied the e$ects of puri-
"ed IgGs on myenteric neurons of the guinea pig ileum. Pressure application of the patient IgGs via a pipette 
located directly above the ganglia resulted in excitation of a subpopulation of neurons (Fig. 2). Action potential 
discharge occurred a'er a short latency and usually lasted throughout the recording period of several seconds. 
#e excitatory response consisted of a fast onset action potential discharge or an increase in spike discharge in 
spontaneously spiking neurons. #e excitatory e$ect of the ANNA-1 samples was signi"cantly stronger than the 
e$ect of the control samples (Fig. 2). When we analyzed the responses to two repeated applications of the same 
ANNA-1 sample (performed for samples from patients #9, #10, #20) we found no signi"cant di$erences in the 
number of responding neurons (25 out of 62 vs. 22 out of 62, p = 0.6, 3 tissues/3 ganglia/62 neurons) or spike 
frequency (1.4 ± 1.3 Hz vs. 1.2 ± 1.5 Hz, p = 0.46) between the 2 applications.
#e nerve activation was evident at 1:100 dilutions but more robust e$ects were seen with 1:1 dilutions. #e 
patient ANNA-1 titer to achieve staining was much higher than 1:1 and the IgG concentration in control samples 
was as high as in patient serum (Table 1). It was therefore not surprising that there was poor correlation between 
total IgG content or ANNA-1 titer and the percentage of responding neurons (total IgG: r = − 0.52, P = 0.23, titer: 
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r = − 0.32, P = 0.49), spike frequency (total IgG: r = 0.24, P = 0.60, titer: r = 0.69, P = 0.08) or neuroindex (total 
IgG: r = − 0.40, P = 0.37, titer: r = − 0.14, P = 0.76).
Figure 1. ANNA-1 sera and puri!ed IgG fractions label guinea pig enteric neurons. Puri"ed IgGs from 
patients with high ANNA-1 titer (a), but not IgGs from healthy controls (b), strongly label nerve cell bodies in 
the guinea pig myenteric plexus. Puri"ed anti-HuD also reveals staining of enteric neurons (c), which remains 
a'er preincubation with the HuD fragment aa90-101 (d) but is blocked by preincubation with the HuD antigen 
(e). Labeling of enteric nerve cell bodies by whole serum is similar to staining with patient IgGs or puri"ed anti-
HuD (f). #is labeling is identical to that obtained with a commercial HuC/D antibody (g) and merged image 
in (h). Anti-NSE labels nerve cell bodies and "bers in a human submucous ganglion (i). FCγ receptor staining 
with CD64 antibody labels nerve "bers only in the same ganglion (j) and merged image in (k). Serum was 
diluted 1:10,000, puri"ed IgGs from patient or control 1:500 and puri"ed anti-HuD 1:20,000; see methods for 
other antibodies.
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Since recording of nerve activity in the human myenteric plexus is not technically feasible, we instead exam-
ined the e$ect of the puri"ed IgGs from patients or controls on human submucous neurons (72 specimens from 
41 donors). Here, we also found excitatory e$ects which were much stronger for patient than for control IgGs 
(Fig. 2). Repeated applications of patient IgGs resulted in comparable responses (61 out of 101 vs. 58 out of 101 
responding neurons, P = 0.6; spike frequency of 2.4 ± 1.9 Hz vs. 2.8 ± 2.5 Hz, P = 0.09, 7 tissues/10 ganglia/101 
neurons). Similar to our "ndings in guinea pig tissue, we found no correlations between total IgG content or anti-
body concentration (titer) and the percentage of responding neurons (total IgG: r = 0.38, P = 0.40, titer: r = 0.30, 
P = 0.51), action potential frequency (total IgG: r = 0.33, p = 0.47, titer: r = 0.47, P = 0.29) or neuroindex (total 
IgG: r = 0.35, P = 0.44, titer: r = 0.40, P = 0.37).
#e nerve activating e$ect of the patients IgGs was more pronounced in human submucous neurons than 
guinea pig myenteric neurons. Both the number of responding neurons (11.6 ± 8.3% vs. 50.4 ± 24.3%, P = 0.01) 
and the spike frequency (1.8 ± 0.6 Hz vs. 2.8 ± 1.2 Hz P = 0.03) was higher in human submucous neurons. Samples 
Figure 2. Puri!ed IgG from patients but not from healthy controls activate enteric neurons. High 
resolution image of a ganglion in the human submucous plexus a'er incubation with the voltage sensitive 
dye Di-8-ANEPPS (a). #e dye incorporates into the outer membrane and reveals the outline of nerve cell 
bodies. Example traces of one of the neurons (marked by arrow) show a fast onset spike discharge a'er brief 
spritz application (bars below traces) of puri"ed IgG from patient #3 (c) but no response to IgG from healthy 
control # 23 (d). #e serum of patient #27 (e) and the puri"ed anti-HuD from this patient (f) both also evoke 
an immediate spike discharge. #e degree of nerve activation is shown in panels g-I. #ey reveal that the 
patient IgGs evoked a signi"cantly stronger spike discharge in a larger proportion of guinea pig (GP) and 
human enteric neurons. As a result the neuroindex was also signi"cantly higher. Open circles are results based 
on application of puri"ed IgG from 8 healthy controls in 46 ganglia and 1296 neurons from 18 guinea pig 
myenteric plexus or 33 ganglia and 258 neurons from 23 human submucous plexus preparations. Color-"lled 
circles represent results from application of puri"ed IgG from 7 patients in 57 ganglia and 1526 neurons from 23 
guinea pig myenteric plexus or 36 ganglia and 304 neurons from 22 human submucous plexus preparations.
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which evoked a higher spike frequency in guinea pig enteric neurons, also had a stronger e$ect in human enteric 
neurons (r = 0.8, P = 0.036).
#e complete serum (#27) activated guinea pig myenteric neurons in a comparable manner to that observed 
a'er application of the patient IgGs (Fig. 2). #e nerve activation occurred in 224 out of 643 neurons (3 tissues/17 
ganglia) and evoked a median spike discharge of 3.1 Hz [1.6/4.7]. Activation of human submucous neurons by the 
complete serum (#27) occurred in 35 out of 123 neurons (12 tissues/14 ganglia) with a median spike frequency 
of 2.4 Hz [1.2/4.0].
#e puri"ed anti-HuD mimicked the e$ects of the serum of this patient (#27) and the e$ects evoked by the 
patient IgGs. Anti-HuD evoked a spike discharge of 2.2 Hz [1.3/3.5] in 38% of guinea pig myenteric neurons (226 
out of 863 neurons) (Fig. 3).
In order to determine if the anti-HuD induced nerve activation was mediated by the binding of the paratope to 
a neuronal target, we tested whether preincubation with the HuD antigen or 90–101aa HuD fragment prevented 
the e$ect. #e anti-HuD IgG (dilution 1:1, ~1 µ mol/l) activated 134 out of 484 neurons which "red at 1.3 Hz 
[0.4/1.7]. Preincubation with the HuD antigen (67 µ M/l) signi"cantly reduced the number of responding neu-
rons (37 out of 484, P < 0.0001) and the spike frequency (0.0 Hz, [0.0/0.4], P < 0.001). Preincubation of anti-HuD 
(dilution 1:10, ~0.1 µ M) with the 90–101aa HuD fragment (6.7 µ M) similarly reduced the nerve activation by 
anti-HuD. While 35 out of 131 neurons "red a'er anti-HuD at a frequency of 1.3 Hz [0.4/2.2] the number of 
responding neurons as well as the spike frequency decreased a'er preincubation with the HuD fragment to 22 out 
of 131 (p = 0.009) and 0.4 Hz [0.0/0.9] (P < 0.001), respectively.
Because the excitatory e$ect of anti-HuD could be mediated by pre- or postsynaptic targets, we applied 
anti-HuD IgG in the absence and presence of ω -Conotoxin GVIA (60 nM) in preparations of the human submu-
cous plexus. ω -Conotoxin GVIA is a blocker of N-type calcium channels that blocks electrically induced synap-
tic responses in the ENS when recorded with voltage sensitive dye imaging17,22, Ca++ imaging23 or intracellular 
electrodes (virtually abolished)24. We found no signi"cant di$erence in the response to anti-HuD before and a'er 
ω -Conotoxin GVIA (spike frequency 3.4 ± 2.9 Hz vs. 2.6 ± 1.9 Hz, P = 0.162), suggesting a direct, postsynaptic 
e$ect of the antibodies (Fig. 3). #ese "ndings argued against presynaptic action of the sera. However, we also 
wanted to rule out the possibility that neural spiking was a consequence of glia activation. We therefore per-
formed Ca++ imaging in guinea-pig myenteric and human submucous neurons followed by immunohistochem-
ical staining for the neuronal marker NSE (Fig. 4). Application of serum #27 to guinea pig myenteric neurons 
resulted in a Ca++ signal in 41% of the cells (33 out of 81) with an increase in Ca++ of 25.2% [21.2/38.7] ∆ F/F. 
Similar results were obtained in human submucous plexus where 50% of the cells (14 out of 28) responded with 
an increase in Ca++ of 28% [24.0/46.5] ∆ F/F. #ose ganglion cells which responded to the ANNA-1 serum were 
neurons because they were all NSE immunoreactive or responded to nicotine which evoked immediate activation 
only in enteric neurons but not glia (Fig. 4).
#e fast onset response a'er application of the serum #27, the patient IgGs as well as the puri"ed anti-HuD 
was striking. We therefore analysed in detail the delay between the beginning of the pressure application and the 
"rst action potential. In guinea pig preparations the "rst action potential in response to application of puri"ed 
anti HuD, serum #27 and ANNA-1 sample #3 occurred a'er 316.9 ms [198.2/528.4] (n = 38 neurons), 425.4 
[300.4/731.3] (n = 27 neurons) and 453.0 ms [357.7/682.9] (n = 13 neurons). #e latency a'er nicotine application 
was not di$erent and the "rst action potential occurred at 349.4 ms [185.1/883.9] (n = 27 neurons, P = 0.08). #is 
lack of signi"cant di$erence in latency was true also in human preparations (P = 0.44). #e "rst spike a'er applica-
tion of nicotine, puri"ed anti HuD or ANNA-1 sample #3 occurred a'er 251.3 ms [194.8/577.1] (n = 20 neurons), 
442.9 ms [287.8/520.7] (n = 14 neurons) or 310.2 ms [213.9/720.3] (n = 27 neurons), respectively. #ese data sug-
gest that ionotropic receptors may be one of the targets of anti-HuD; in the ENS the most prominent among them 
are nicotinic, P2X and 5-HT3 receptors25,26. We found that hexamethonium signi"cantly reduced the response to 
the serum #27 as indicated by the reduced number of responding neurons (37 out of 102 neurons vs. 9 out of 102 
in hexamethonium, P < 0.001) and the decreased spike frequency (1.2 Hz [0.8/2.4] vs. 0.2 Hz [0.0/1.2] in hexame-
thonium, P < 0.001) (Fig. 3). Similarly, hexamethonium decreased the spike frequency evoked by the IgG samples 
of patients #2, 8 and #10 (only those were used) from 1.2 Hz [0.4/2.1] to 0 Hz [0.0/0.0], P = < 0.001, n = 14 neu-
rons]. #e nerve activation by puri"ed anti-HuD was also reduced by hexamethonium and in addition by DHβ 
E from 1.3 Hz [0.8/2.0] to 0.4 Hz [0.0/1.88] (n = 19 neurons, P = 0.002) and 1.2 Hz [0.4/3.0] to 1.0 Hz [0.3/1.6] 
(P = 0.048, n = 22 neurons), respectively. #e P2X antagonist PPADS (10 µ M) reduced the action potential fre-
quency in response to serum #27 signi"cantly from 1.3 ± 0.9 Hz to 0.8 ± 0.7 Hz (n = 18 neurons, p = 0.004). In 
contrast, we did not "nd evidence for involvement of 5-HT3 receptors. #e 5-HT3 antagonist tropisetron (0.1 µ M) 
did not change the IgG evoked nerve activation (spike frequency: 1.2 ± 0.8 Hz vs. 1.4 ± 1.2 Hz, p = 0.3, n = 6 
neurons).
???????????????????? Puri"ed anti-HuD (dilution 1:10) was applied to 15 mechanosensitive “hot spots” 
from 10 mice and a total of 20 units were analyzed. 18 out of 20 units (90%) responded with a signi"cant increase 
in "ring rate by 18.3 Hz [11.0/27.5] (mean latency 25.9 ± 4.5 s, peak a'er 75.8 ± 10.7 s) (Fig. 5). #e response 
rapidly desensitized (t1/2 = 10.2 s) but in some cases was sustained until washing out the sample. #is e$ect was 
reproducible based on the "nding that repeated application of anti-HuD to 4 mechanosensitive "bers evoked 
similar spike frequencies ("rst application 9.9 Hz vs 11.3 Hz a'er second application of anti-HuD, p = 0.82). Vagal 
a$erents responded to DMPP and/or ATP but sensitivity to anti-HuD was not correlated to either. A substantial 
number of vagal a$erents terminate in enteric ganglia raising the possibility of activation secondary to an action 
on enteric neurons. However, the response to anti-HuD was not signi"cantly di$erent in calcium-free bu$er from 
that in standard Krebs solution (18.3 Hz [11.0/27.5] n = 18 vs. 15.2 Hz [9.9/33.6] n = 9, p = 0.78). #is "nding sug-
gested that the anti-HuD evoked increase in spike discharge was indeed mediated by direct activation of a$erent 
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Figure 3. Puri!ed IgGs evoked nerve activation is caused by direct postsynaptic activation of neurons and 
prevented or inhibited by preincubation with HuD antigen, the nicotinic receptor blocker hexamethonium 
and the P2X purine receptor antagonist PPADS, respectively. Application of anti-HuD evoked activation of 
guinea-pig enteric neurons (upper trace (a). #e spike discharge was prevented by preincubation with the full 
HuD antigen (lower trace (a) and with the HuD fragment aa90-101. #e graph summarizes the results a'er 
preincubation with HuD antigen (166 neurons, 19 ganglia from 9 guinea pig myenteric plexus preparations) and 
HuD fragment aa90-101 (39 neurons, 4 ganglia from 3 guinea pig myenteric plexus preparations). #e response 
to serum from patient #27 (upper trace (b) is not a$ected by the N-type Ca++ channel blocker ω -conotoxin 
GVIA (lower trace (b) which also blocks all synaptic input (statistics based on 7 neurons, 3 ganglia and 3 human 
submucous plexus preparations). However, the response to serum from patient #27 (upper trace (c) is strongly 
reduced by hexamethonium (lower trace (c) and by the P2X purine receptor antagonist PPADS (statistics based 
on 111 neurons, 10 ganglia, 8 guinea pig myenteric plexus preparations for hexamethonium and 18 neurons, 4 
ganglia, 2 guinea pig myenteric plexus preparations for PPADS).
www.nature.com/scientificreports/
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Figure 4. ANNA-1 serum from patient #27 evokes neuronal Ca++ responses. ANNA-1 serum speci"cally 
activates neurons in the human submucous (a and b) and the guinea-pig myenteric plexus (c and d). Panel 
a shows a human submucous ganglion a'er NSE staining which labels only neurons. #e Ca++ traces of two 
neurons (marked by red arrows) following application of serum #27 are shown in panel B (application of serum 
indicated by the bar). Panel c shows a guinea pig myenteric ganglion a'er NSE staining. #e Ca++ responses of 
the neurons marked by black arrows are shown in panel d as color coded signals 13 sec a'er application of the 
serum (red = high activity – blue = no activity).
Figure 5. Puri!ed anti-HuD augments spike discharge in visceral sensory nerve !bers. Panel a is an 
example of a sequential rate histogram showing an increase in spike discharge shortly a'er application of the 
anti-HuD. #e traces below are sample neurograms showing the spike discharge before and a'er anti-HuD. 
#e graph in b summarizes results from several such experiments and revealed a signi"cant increase in spike 
discharge rate by anti-HuD (recordings from 20 a$erent nerves in 15 mouse stomach preparations) which was 
not a$ected in Ca++ free bu$er (recordings from 9 a$erent nerves in 6 mouse stomach preparations).
www.nature.com/scientificreports/
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"bers rather than by indirect activation followed by the release of excitatory enteric neurotransmitters. #is was 
the case for both phasic and sustained components of the a$erent response (Fig. 5).
Discussion
We demonstrated that ANNA-1 autoantibodies from patients with paraneoplastic GI syndromes labelled all neu-
rons in the myenteric plexus of the guinea pig. In functional studies, ANNA-1 autoantibodies had an excitatory 
e$ect on human and guinea pig enteric neurons as well as on mouse visceral a$erents, which was reproducible 
upon repeated applications. Using receptor antagonists we reveal that both nicotinic (β 2 subunit) and purinergic 
P2X receptors are implicated in the responses to ANNA-1 autoantibodies. Activation of enteric or visceral a$er-
ent nerves was likely to be a direct e$ect because the spike discharge did not change a'er synaptic blockade by 
Ca-depletion or ω -conotoxin GVIA. We found that anti-HuD was responsible for this excitatory e$ect because it 
mimicked the excitation evoked by puri"ed IgGs, which was reversed by the HuD antigen. #is is the "rst demon-
stration that ANNA-1 antibodies caused fast onset activation of enteric neurons. #ese acute e$ects of ANNA-1 
antibodies contrast with several long term e$ects of anti-neuronal antibodies which all inhibit excitability, impair 
neuronal functions or even irreversibly damage or kill neurons27–30.
Although the most-established role of HuD is in neurogenesis, it also plays a role in neuronal survival, plasticity 
during learning and memory, and following neuronal injury. Despite HuA, HuB, HuC and HuD proteins sharing 
more than 80% homology, there are some noteworthy di$erences, which suggest unique functions of HuD. #us, 
the spatial expression of HuD mRNA and the amino acid sequence in the N-terminal region of HuD are di$erent 
from the other Hu proteins31. Although loss of function of Hu proteins impact on neuronal signaling because of 
impaired RNA stabilization, there is so far no evidence for direct involvement of HuD in neuronal excitability.
Only a few studies have shown direct activation of neurons in response to application of antibodies32–35. An 
antibody directed against the glutamate receptor 3B protein activated hippocampal neurons28. In two other stud-
ies, binding of IgG immune complexes to neuronal Fcγ receptors activated ion channels leading to depolariza-
tion32,34. Finally, neuronal activation occurred a'er application of antibodies against dipeptidyl-peptidase-like 
protein 6, a subunit of Kv4.2 potassium channels33. Other antibodies that excited enteric neurons were 
anti-idiotypic antibodies to 5-HT receptors35. In all studies the targets of the particular antibodies were a 
well-de"ned accessible receptor or ion channel linked to excitability of neurons. It is not clear how the anti-HuD 
antibodies activated neurons because the only known epitope for Hu antibodies in neurons is the nuclear or cyto-
plasmatic Hu protein36,37. Binding of the antibody to an intracellular antigen cannot explain the fast onset excit-
atory e$ects because the internalization of antibodies is a slow process38. On the other hand, it has been shown 
that anti-Hu can bind to antigens that are located on the membrane surface of small cell lung cancer cells and 
neuroblastoma cell lines39. However, the function of this membrane bound target or its presence in non-cancer 
cells is unknown.
#e nuclear and cytoplasmatic binding of anti-HuD very likely mediate the long term e$ects. Our results sug-
gest that the rapid excitatory action of anti-HuD in the ENS involved nicotinic acetylcholine as well as P2X purine 
receptors; molecular coupling between these two receptors have been described in the ENS40,41. Both hexame-
thonium and DHβ E blocked nicotinic receptor mediated fast excitatory postsynaptic potentials in the ENS42. It is 
important to emphasize that anti-HuD did not target ionotropic receptors per se. Blockade of the 5-HT3 receptor, 
which is another widely expressed ionotropic receptor in the ENS, did not alter nerve activation by anti-HuD. 
Our "nding that spike discharge evoked by anti-HuD antibody was prevented by the Hu antigen as well as by the 
HuD fragment aa 90–101 strongly suggested that the excitatory e$ect depended on the anti-Hu paratope of the 
antibody, even though the HuD fragment aa 90–101 did not a$ect the staining. Notably, anti-HuD also activated 
visceral sensory nerves although we (this study) and others did not observe staining of terminal endings of vis-
ceral a$erent with any anti-Hu antibody43.
#e ANNA-1 samples showed strong staining of virtually all neurons in the guinea pig myenteric plexus, 
while we detected the excitatory e$ects only in a subpopulation of neurons (median 12% in guinea-pig and 50% 
in human enteric neurons). Likewise, anti-HuC/D antibodies label all guinea pig and human enteric neurons9,37 
but the anti-HuD activated only a subpopulation of neurons. #is suggests that labeling and neuronal activation 
may occur independently. #ere was also a mismatch between the number of neurons responding to ANNA-1 
(50% in human submucous plexus) and the proportion of neurons functionally expressing the nicotinic receptor 
(more than 90% based on the occurrence of nicotinic fast EPSPs)17. #is is unlikely to be related to any lack of sen-
sitivity of voltage sensitive dye recording to detect neuronal activation associated with action potentials discharge 
since similar responses were obtained using the more sensitive Ca++ imaging. #e simplest explanation relates to 
di$erential a%nity or access of ANNA-1 IgGs to ganglionic nicotinic receptors. Alternatively, ANNA-1 IgGs may 
preferentially activate nicotinic receptors with particular subunit composition. Enteric neurons express α 3-, α 4-, 
α 3/α 5-, β 2-, β 4- and α 7-nicotinic receptor subunits in di$erent heteromeric combinations but all contributed to 
the excitatory e$ects of the most important enteric excitatory transmitter acetylcholine44. #e excitatory e$ect of 
ANNA-1 IgGs in the present study was reduced by the β 2-subunit preferring antagonist dihydro-β -erythroidine 
which may suggest some selectivity. However, a contribution of P2X receptor activation is also implicated from 
the inhibitory action of PPADS. #us there may be multiple molecular targets for antibody binding and activation. 
It is unlikely that the nerve-stimulatory e$ect of the HuD antibody was due to its binding to the intracellular Hu 
protein for a number of reasons. Firstly, the antibody e$ect on nerve activation is unrelated to the level of immu-
nostaining. In addition, use of the Basic Local Alignment Search Tool (https://blast.ncbi.nlm.nih.gov/Blast.cgi) 
to search for homologies with Hu proteins did not reveal any similarity in amino acid sequence to any other 
known protein, including nicotinic or P2X receptor subunit. However, the antibody binding may only be revealed 
by modelling the 3D structure of the antibody and the receptor. Secondly, the short latency for neuronal activa-
tion suggested an extracellular target. #e "nding that the response latencies for nicotine and IgGs were similar 
led us to focus on ionotropic receptor involvement in anti-HuD evoked action potential discharge. #is "nding 
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combined with the e$ect of ionotropic receptor antagonists is consistent with nicotinic and P2X receptor involve-
ment. We cannot at this stage fully rule out contribution of metabotropic receptors. However, in our experience 
spike discharge induced by activation of metabotropic receptors has longer onset latency, at least when using 
voltage sensitive dye recording. Of course, it is also possible that the primary target of anti-HuD is not a receptor 
but some structure which is functionally linked to nicotinic and P2X receptors.
It was previously shown that an IgG immune complex formed from mouse IgG as antigen and a%nity-puri"ed 
rat anti-mouse IgG as antibody (but neither antigen nor antibody alone), evoked Ca++ signals in dorsal root gan-
glion neurons through activation of neuronal Fcγ receptor I45. However, a possible activation of the Fcγ receptor 
may be ruled out in our study because the immune complex (through pre-incubation with HuD) had no excitatory 
e$ect, but prevented the anti-HuD evoked nerve activation. In addition, there was no Fcγ receptor immunoreac-
tivity in enteric nerve cell bodies (see Fig. 1). We did, however, detect Fcγ receptor immunoreactivity in extrinsic 
nerve "bers running within the submucous plexus, likely terminals of sensory neurons expressing Fcγ receptor45.
Also, anti-HuD antibodies activated mechanosensitive visceral a$erents. #is "nding suggested that a sensi-
tization of mechanosensitive "bers, besides the activation of enteric neurons, may contribute to clinical symp-
toms related to gut dysfunction in patients with high ANNA-1 titers46. #e exact link between nerve excitation 
and symptoms such as pseudoobstruction or gastroparesis remain to be studied. Although our "ndings do not 
provide direct evidence it is tempting to speculate that the acute e$ects of anti-Hu on neuronal excitability (both 
spike discharge as well as Increase in intracellular Calcium) may with chronic exposure under pathological con-
ditions lead to neuronal damage similar to that observed when primary culture of enteric neurons are exposure 
for several hours to ANNA-1 sera8,47.
In summary, we demonstrated excitatory e$ects of ANNA-1 IgGs on human and guinea pig enteric neurons 
as well as on mouse visceral a$erents. #ese data suggest that anti-HuD IgG cause direct nerve activation via a 
mechanism involving nicotinic and P2X receptors. Although the clinical impact of these "ndings remain to be 
determined, our data imply that neuronal enteric and a$erent excitation triggered by anti-HuD antibodies can 
play a role in symptom generation in patients with autoimmune-related GI dysfunction.
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